Literature DB >> 3161503

Radioimmunoassay of atrial natriuretic factor: human plasma levels.

P Larose, S Meloche, P du Souich, A Deléan, H Ong.   

Abstract

A simple and sensitive radioimmunoassay procedure has been developed for the determination of atrial natriuretic factor (ANF) in human plasma. The rabbit antiserum was obtained from a commercial source. ANF was extracted from plasma using an octadecasilyl silica cartridge with a recovery of 78.7%. HPLC of the plasma extract showed the presence of one immunoreactive peak of ANF corresponding to its low molecular weight form. Plasma ANF in humans increased from 8.0 +/- 2.2 in upright position to 20.0 +/- 5.9 fmol/ml (n = 6) in downward position (p less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161503     DOI: 10.1016/0006-291x(85)90452-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.

Authors:  M Kohno; K Yasunari; K Yokokawa; K Murakawa; T Horio; T Takeda
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Diuretic treatment in decompensated cirrhosis and congestive heart failure.

Authors:  A L Gerbes; R M Arendt
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

3.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

4.  Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.

Authors:  A Kurtz; R Della Bruna; J Pfeilschifter; R Taugner; C Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

6.  Effect of dehydration and hyperosmolal hydration on lignocaine and metabolites disposition in conscious rabbits.

Authors:  M Chamelian; A Lécrivain; A Robichaud; P du Souich
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

7.  Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans.

Authors:  M Epstein; R Loutzenhiser; E Friedland; R M Aceto; M J Camargo; S A Atlas
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension.

Authors:  P Larochelle; J R Cusson; J Gutkowska; E L Schiffrin; P Hamet; O Kuchel; J Genest; M Cantin
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

9.  Furosemide dynamics in conscious rabbits: modulation by angiotensin II.

Authors:  W Homsy; S Marleau; P du Souich
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

10.  Muscarinic effect of atrial natriuretic peptide on rabbit airways.

Authors:  A Robichaud; C Saunier; M C Michoud; P du Souich
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.